• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

3,5-二甲基-1-硫代羰基吡唑及其 Pd(II) 配合物的合成、光谱研究及抗肿瘤活性。

3,5-Dimethyl-1-thiocarbamoylpyrazole and its Pd(II) complexes: synthesis, spectral studies and antitumor activity.

机构信息

Departamento de Química Geral e Inorgânica, Instituto de Química de Araraquara, UNESP-University Estadual Paulista, P.O. Box 355, Araraquara, São Paulo 14801-970, Brazil.

出版信息

Eur J Med Chem. 2010 May;45(5):1698-702. doi: 10.1016/j.ejmech.2009.12.073. Epub 2010 Jan 14.

DOI:10.1016/j.ejmech.2009.12.073
PMID:20116142
Abstract

Complexes of the type [PdX2(tdmPz)] {X=Cl-(1), Br-(2); I-(3); SCN-(4); tdmPz=1-thiocarbamoyl-3,5-dimethylpyrazole} have been synthesized and characterized. Compound 1 was formed from the reaction between [PdCl2(CH3CN)2] and 1-thiocarbamoyl-3,5-dimethylpyrazole. Complexes 2, 3 and 4 were obtained by metathesis of the chloro groups from 1 by bromide, iodide and thiocyanate ions, respectively. All the compounds and cisplatin have been tested in vitro by MTT assay for their cytotoxicity against three murine cancer cell lines: mammary adenocarcinoma (LM3 and LMM3) and lung adenocarcinoma (LP07) as well towards normal murine peritoneal exudate cells (PEC). Promising cytotoxic effect against LM3 has been found for 3 showing IC50 equal to 24.5 microM which is comparable to the value obtained for cisplatin (30.3 microM).

摘要

已经合成并表征了[PdX2(tdmPz)]类型的配合物,其中 X=Cl-(1),Br-(2),I-(3),SCN-(4),tdmPz=1-硫代羰酰基-3,5-二甲基吡唑。化合物 1 是由[PdCl2(CH3CN)2]与 1-硫代羰酰基-3,5-二甲基吡唑反应生成的。配合物 2、3 和 4 是通过 1 中氯原子的转移反应由溴化物、碘化物和硫氰酸根离子分别得到的。所有化合物和顺铂都通过 MTT 测定法在体外对三种鼠癌细胞系(乳腺腺癌(LM3 和 LMM3)和肺腺癌(LP07))以及对正常鼠腹腔渗出细胞(PEC)的细胞毒性进行了测试。发现 3 对 LM3 具有有前途的细胞毒性作用,其 IC50 为 24.5 microM,与顺铂(30.3 microM)的值相当。

相似文献

1
3,5-Dimethyl-1-thiocarbamoylpyrazole and its Pd(II) complexes: synthesis, spectral studies and antitumor activity.3,5-二甲基-1-硫代羰基吡唑及其 Pd(II) 配合物的合成、光谱研究及抗肿瘤活性。
Eur J Med Chem. 2010 May;45(5):1698-702. doi: 10.1016/j.ejmech.2009.12.073. Epub 2010 Jan 14.
2
Synthesis, characterization, interaction with DNA, and cytotoxic effect in vitro of new mono- and dinuclear Pd(II) and Pt(II) complexes with benzo[d]thiazol-2-amine as the primary ligand.新型单核和双核 Pd(II)和 Pt(II)配合物的合成、表征、与 DNA 的相互作用及体外细胞毒性研究,配体为苯并[d]噻唑-2-胺。
Inorg Chem. 2011 Jun 6;50(11):4732-41. doi: 10.1021/ic102142j. Epub 2011 Apr 26.
3
Antimycobacterial and antitumor activities of palladium(II) complexes containing isonicotinamide (isn): X-ray structure of trans-[Pd(N3)2(isn)(2)].含异烟酰胺(isn)的钯(II)配合物的抗分枝杆菌和抗肿瘤活性:[Pd(N3)2(isn)(2)]的 X 射线结构。
Eur J Med Chem. 2010 Nov;45(11):4863-8. doi: 10.1016/j.ejmech.2010.07.057. Epub 2010 Aug 6.
4
Synthesis, characterization and assessment of the cytotoxic properties of cis and trans-[Pd(L)(2)Cl(2)] complexes involving 6-benzylamino-9-isopropylpurine derivatives.涉及6-苄基氨基-9-异丙基嘌呤衍生物的顺式和反式-[Pd(L)(2)Cl(2)]配合物的合成、表征及细胞毒性性质评估
J Inorg Biochem. 2007 Mar;101(3):477-92. doi: 10.1016/j.jinorgbio.2006.11.010. Epub 2006 Nov 23.
5
Synthesis and characterization of new palladium-clotrimazole and palladium-chloroquine complexes showing cytotoxicity for tumor cell lines in vitro.新型钯-克霉唑和钯-氯喹配合物的合成与表征:体外对肿瘤细胞系显示细胞毒性
J Inorg Biochem. 2006 Jan;100(1):152-7. doi: 10.1016/j.jinorgbio.2005.10.013. Epub 2005 Dec 15.
6
Synthesis, structural characterization, and antitumor activity of palladium(II) complexes containing a sugar unit.含糖单元的钯(II)配合物的合成、结构表征及抗肿瘤活性
Bioorg Med Chem Lett. 2004 May 17;14(10):2533-6. doi: 10.1016/j.bmcl.2004.02.095.
7
Nickel (II) complexes of naphthaquinone thiosemicarbazone and semicarbazone: synthesis, structure, spectroscopy, and biological activity.萘醌硫代半卡巴腙和半卡巴腙的镍(II)配合物:合成、结构、光谱学及生物活性
J Inorg Biochem. 2005 Jul;99(7):1526-31. doi: 10.1016/j.jinorgbio.2005.04.012.
8
Synthesis and chemical-pharmacological characterization of the antimetastatic NAMI-A-type Ru(III) complexes (Hdmtp)[trans-RuCl4(dmso-S)(dmtp)], (Na)[trans-RuCl4(dmso-S)(dmtp)], and [mer-RuCl3(H2O)(dmso-S)(dmtp)] (dmtp = 5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidine).抗转移的NAMI-A型钌(III)配合物(Hdmtp)[反式-RuCl4(二甲基亚砜-S)(dmtp)]、(Na)[反式-RuCl4(二甲基亚砜-S)(dmtp)]和[顺式-RuCl3(H2O)(二甲基亚砜-S)(dmtp)](dmtp = 5,7-二甲基[1,2,4]三唑并[1,5-a]嘧啶)的合成及化学-药理学表征
J Med Chem. 2004 Feb 26;47(5):1110-21. doi: 10.1021/jm030984d.
9
Cytotoxic activity of Gd(III)- and Dy(III)-complexes.钆(III)和镝(III)配合物的细胞毒性活性。
Arch Pharm (Weinheim). 2007 Dec;340(12):642-9. doi: 10.1002/ardp.200700118.
10
New palladium(II) complexes bearing pyrazole-based Schiff base ligands: synthesis, characterization and cytotoxicity.新型含吡唑基席夫碱配体的钯(II)配合物的合成、表征及细胞毒性。
Eur J Med Chem. 2010 Feb;45(2):471-5. doi: 10.1016/j.ejmech.2009.10.029. Epub 2009 Oct 29.

引用本文的文献

1
Chemotherapeutic Activities of New η--Cymene Ruthenium(II) and Osmium(II) Complexes with Chelating SS and Tridentate SNS Ligands.新型η-对异丙基苯钌(II)和锇(II)与螯合SS和三齿SNS配体配合物的化疗活性
Molecules. 2024 Feb 21;29(5):944. doi: 10.3390/molecules29050944.
2
Anticancer and antimicrobial properties of novel η--cymene ruthenium(ii) complexes containing a N,S-type ligand, their structural and theoretical characterization.含N,S型配体的新型η-对异丙基苯钌(II)配合物的抗癌和抗菌性能、其结构及理论表征
RSC Adv. 2019 Nov 27;9(66):38629-38645. doi: 10.1039/c9ra08736b. eCollection 2019 Nov 25.
3
Selected polyoxopalladates as promising and selective antitumor drug candidates.
选定的多氧钯酸盐作为有前景的选择性抗肿瘤药物候选物。
J Biol Inorg Chem. 2021 Dec;26(8):957-971. doi: 10.1007/s00775-021-01905-4. Epub 2021 Sep 21.